IRadimed has received 510(k) clearance from the FDA for MRidium 3860+MRI infusion system. The device, which features Masimo Set SpO2 monitoring, allows patients to get MRI screening while undergoing infusion treatment.
Published in Brief:
|Assistant General Counsel, Regulatory FDA||
|Assistant General Counsel||
|Regulatory Affairs Specialist||
|Sr. Principal OptoMechanical Engineer - 14000008M2||
|San Jose, CA|
|Senior Director Medical Affairs||